Tsuruha Pharmaceutical

Tsuruha Pharmaceutical is a specialized subsidiary of Tsuruha Holdings, one of Japan's largest and most prominent drugstore operators. Established in 2018, the company serves as the central hub for the planning, development, and quality management of private-label (PB) pharmaceutical products across the group's extensive retail network. Its portfolio encompasses a wide range of over-the-counter (OTC) medications, quasi-drugs, and health supplements designed to meet consumer demand for affordable healthcare. The company focuses on vertical integration, ensuring quality control and cost-efficiency for products sold under brands like M's One. While it does not engage in high-risk clinical R&D for novel molecular entities, it plays a vital role in the Japanese consumer health landscape by leveraging the massive retail footprint of its parent company.